Catherine Matthes

Venture Advisor at Cultivation Capital

View Live Interactive Profile →

Biography

Catherine Matthes is listed on Cultivation Capital's team page with the title Venture Advisor. She is Founder and Managing Member of MedFINiti, LLC, which provides contracted financial, operational, transactional and strategic services to venture-backed life sciences and medtech businesses, and her firm profile records over thirty years in leadership, business development and operations roles at early-stage and established life science companies. She was Chief Financial Officer of Veniti, Inc., the venous stent company sold to Boston Scientific in 2018, and previously worked in public accounting, where she obtained her CPA. She holds a BSBA from the University of Missouri. A record was created for her despite the advisory title because the Form D for Cultivation Capital Life Sciences Fund IV, LP names her as a Director, Promoter and Managing Director of the fund's general partner, which is a partner-level decision-making role.

Education

Previous Experience

Career Timeline

2018
Veniti, Inc., where she was Chief Financial Officer, is sold to Boston Scientific.
2025
Named as a Director, Promoter and Managing Director in the Form D for Cultivation Capital Life Sciences Fund IV, LP.

Sources & References

Cultivation Capital - Catherine Matthes ↗Cultivation Capital - Team ↗SEC Form D - Cultivation Capital Life Sciences Fund IV, LP ↗